Bacterial genomics have revealed the widespread occurrence of eukaryotic-like protein kinases in prokaryotes, but little is known about their regulation, endogenous substrates, and physiological role. The present study concerns one of these enzymes, the serine/ threonine protein kinase PknF from Mycobacterium tuberculosis. It is shown that, in addition to its autokinase activity, PknF is able to phosphorylate Rv1747, a newly described ABC transporter. This reaction appears to involve two FHA domains of Rv1747. It is suggested that recruitment and phosphorylation of Rv1747 depend on the interaction between its two non-redundant FHA domains and the autophosphorylated form of PknF.
Introduction
For many years after the discovery of protein phosphorylation catalyzed by serine/threonine protein kinases (STPKs), the prevailing view was that these enzymes were present only in eukaryotes [1] . However, since the identification of bacterial homologues a few years ago [2, 3] , genomics has now demonstrated that serine/threonine protein kinases and phosphatases are also widespread in prokaryotes [4, 5] . In the case of Mycobacterium tuberculosis, analysis of the genome sequence has predicted the presence of 11 different STPKs [6, 7] . Eight of these appear to be transmembrane proteins, with a putative extracellular signal sensor domain and an intracellular kinase domain. Among them, PknA, PknB, PknD, PknE, PknF, and PknG have been shown, so far, to catalyze autophosphorylation [8] [9] [10] [11] [12] [13] [14] but none has been yet demonstrated to phosphorylate endogenous protein(s). To date, only PknH has been shown to phosphorylate an endogenous substrate, EmbR, which is a putative transcriptional activator that belongs to the OmpR-like family [15] . Moreover, it has been demonstrated that EmbR phosphorylation by PknH is mediated by an FHA (forkhead associated) domain [15] .
An FHA domain is a phosphopeptide recognition domain with a 55-to 75-amino-acid homology region forming an 11-stranded b-sandwich that mediates specific phosphorylation-dependent protein-protein interaction [16] [17] [18] [19] . Although FHA containing proteins are present in all phyla from bacteria to mammals, the specific interaction partners of individual FHA domains are poorly understood. Indeed, till now, phosphorylation of EmbR by PknH constitutes the unique experimental characterization of such phosphorylation-dependent protein-protein interaction in bacteria, even though 64 bacterial FHA proteins are currently listed in the SMART database (http://smart.ox.ac.uk). Since regulatory phosphorylation by STPKs is an emerging theme in prokaryotic signaling, the identification of protein substrates specifically phosphorylated by prokaryotic STPKs is needed to decipher the bacterial signaling pathways. Analysis of the M. tuberculosis genome database has revealed that only six genes (rv0019c, rv0020c, rv1747, embR, Rv1827, and Rv1860) encode putative FHA-containing proteins [20] . Interestingly, among these genes, rv1747 encodes a putative ATP-binding cassette (ABC) transporter [21] , and is located in the same operon as pknF, which has been demonstrated to encode a Ser/Thr protein kinase [14] . ABC transporters act as mechanical pumps that couple ATP hydrolysis to either the uptake or export of a wide diversity of substrates across biological membranes including ions, sugars, lipids, peptides, and complex organic molecules [22] . These transporters have a similar topology, with two transmembrane domains and two nucleotide-binding domains, that can be found on either the same polypeptide or as many as four different polypeptides. In the case of ABC importers, an additional subunit, termed SBP for ''substrate-binding protein'', is involved in both the capture and the docking of the extracellular substrate onto the transporter [22] .
Considering that both Rv1747 and EmbR contain a FHA domain and that the corresponding genes, pknF and rv1747, are adjacent along the chromosome, it seemed of interest to study the possible cross-regulation of PknF and Rv1747. In this work, we describe the overproduction and purification of the nucleotidebinding domain (NBD) of Rv1747 and the assessment of its ATPase activity. Also, the cytosolic kinase domain of PknF has been overproduced and purified and the capacity of this kinase, besides its autophosphorylation activity, to phosphorylate the NBD of Rv1747 has been tested. In addition, the effects of the two FHA domains of Rv1747 on the level of its trans-phosphorylation by PknF have been determined.
Materials and methods

Bacterial strains, plasmids, and growth conditions
Strains, plasmids, and primers used in this study are listed in Tables 1 and 2 . Overproduction of NBD and PknF 1-292 was performed, respectively, in E. coli strain BL21 (pRep4-groESL) [23] and BL21(DE3) [24] . E. coli DH5 strain [25] was used to propagate plasmids in cloning experiments. All strains were grown and This study maintained in LB medium at 37°C. When required, media were supplemented with either 50 lg/ml ampicillin or 25 lg/ml kanamycin.
Construction of GST-tagged NBD domain and Nustagged PknF expression plasmids
The 1677-bp Rv1747 gene fragment, with appropriate restriction sites at both ends, was synthesized by PCR amplification using M. tuberculosis H37Rv genomic DNA as a template and primer pair 135/99 (Table 2 ). This DNA fragment was ligated into vector pGEX(M), thus yielding pGEX-NBD ( Table 1 ). The 876-bp pknF gene fragment corresponding to the cytosolic domain of PknF, with appropriate restriction sites at both ends, was synthesized by PCR amplification using M. tuberculosis H37Rv genomic DNA as a template and primer pair 94/ 95 (Table 2 ). This DNA fragment was ligated into vector pET44b, thus yielding pET44b-PknF (Table 1 ).
Site-directed mutagenesis
Site-directed mutagenesis was carried out based on PCR amplification with the primer presented in Table 1 , as previously described [15] .
Overproduction and purification of the Nus-PknF 1-292 domain
PknF was purified on Ni-NTA agarose columns as previously described [15] .
2.5. Overproduction of the GST-tagged NBD 1-559 domain and related mutant proteins E. coli BL21(pRep4-groESL) cells were transformed with the pGEX-NBD vector and derivatives expressing the wild-type or mutated NBD 1-559 domain (Table 1) .
Recombinant strains harboring the pGEX-NBD vector and derivatives were used to inoculate 100 ml of LB medium supplemented with ampicillin, and were incubated at 37°C under shaking until A 600 reached 0.5. IPTG was then added at a final concentration of 1 mM and growth was continued for an additional 3 h at 37°C under shaking. E. coli BL21(DE3) cells were transformed with the pET44b-PknF 1-876 vector and derivatives expressing the wild-type or mutated PknF cytoplasmic domain (Table 1) . Recombinant E. coli strains harboring the pET44b-PknF 1-876 vector and derivatives were used to inoculate 50 ml of LB medium supplemented with ampicillin, and were incubated at 37°C under shaking until A 600 reached 0.5. IPTG was then added at a final concentration of 1 mM and growth was continued for an additional 3 h at 37°C under shaking.
Purification of the NBD 1-559 domain and related mutant proteins
Cells were harvested by centrifugation at 6000g for 10 min, washed in 10 ml of phosphate buffer saline (PBS), and centrifuged again in the same conditions. The cell pellet was resuspended in PBS. Cells were disrupted by sonication (Branson Sonifier 250). The resulting suspension was centrifuged at 4°C for 30 min at 30,000g. The supernatant was incubated for 1 h with glutathioneSepharose 4B matrix (Pharmacia Biotech) at 4°C. The protein-resin complex was packed into a column and washed with 50 ml PBS. Protein elution was carried out with elution buffer (50 mM Tris-HCl, pH 8.0, 120 mM NaCl) containing 15 mM glutathione. Eluted fractions were analyzed by SDS-PAGE [26] . After dialysis against buffer C (50 mM Tris-HCl, pH 8.0, 120 mM NaCl, 0.2 mM DTT, 0.2 mM EDTA, and 10% glycerol), pure fractions were pooled and tested for in vitro phosphorylation in the presence of PknF. All mutant proteins were purified in the same conditions.
In vitro kinase assay
In vitro phosphorylation of about 1 lg of PknF was carried out for 15 min at 37°C in a reaction mixture (20 ll) containing buffer P (25 mM Tris-HCl, pH 7.0, 1 mM DTT, 5 mM MgCl 2 , and 1 mM EDTA) with 200 lCi/ml [c-32 P]ATP. Phosphorylation of NBD 1-559 by PknF 1-292 was performed with 5 lg of NBD 1-559 in 20 lg of buffer P with 200 lCi/ml [c-
32 P]ATP and 1 lg of PknF 1-292 for 15 min at 37°C. The reaction was stopped by addition of an equal volume of 2Â sample buffer and the mixture was heated at 100°C for 5 min. One-dimensional gel electrophoresis was performed as described by Laemmli [26] . After electrophoresis, gels were soaked in 16% TCA for 10 min at 90°C, and dried. Radioactive proteins were visualized by autoradiography using direct exposure films. When needed, 
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Results
Overproduction of the nucleotide-binding domain of Rv1747
Analysis of the protein primary structure deduced from M. tuberculosis genome indicated that Rv1747 would belong to the ABC transporter family [21] (Fig. 1) . It was predicted to contain 865 amino acids, with a putative nucleotide-binding domain (NBD) characteristic of the ABC transporter family: this includes the highly conserved Walker A (corresponding to Gly352 to Ser359) and Walker B (corresponding to Leu474 to Asp478) motifs which form an ATP-binding pocket, and the typical signature of the ABC family, the C-motif, a stretch of $12 residues usually starting with the sequence LSGGQ [27] (corresponding to Leu454 to Ala465, see Fig. 1A ). Rv1747 was also predicted to contain six putative transmembrane a-helices in its C-terminal region, likely allowing the translocation of an unknown substrate through the membrane (Fig. 1A) . Moreover, previous sequence analysis had revealed that the N-terminal region of Rv1747 possesses a putative FHA domain highly conserved among orthologues of Rv1747 [20] , spanning from residue Glu224 to Phe299. Interestingly, in a more detailed analysis of the primary sequence of Rv1747, we identified a second region, spanning from residue Phe23 to Ala98, and sharing strong homology with a FHA domain (Fig. 1A and B) . From this observation, the hypothesis was made that Rv1747 would possess in fact two FHA domains, FHA1 and FHA2 (Fig. 1A) , as previously reported in the case of the Rad53 yeast kinase [28] . Considering the possibility that Rv1747 might be a substrate for the serine threonine/kinase PknF, an attempt was made to overproduce and purify the NBD of Rv1747. For that purpose, the truncated Rv1747 gene encoding the NBD (residues 1-559) was synthesized by PCR amplification using genomic DNA from M. tuberculosis H37Rv. The amplified product was then cloned into plasmid pGEX(M) [15] to yield pGEX(M)-NBD and used to transform E. coli cells. The analysis of the GST-chimeric protein by SDS-PAGE revealed that the protein was expressed in a soluble form and was migrating as a unique band with the predicted molecular mass of 85.5 kDa.
NBD 1-559 exhibits ATPase activity
In order to check whether the recombinant protein was able to hydrolyze ATP, NBD 1-559 was incubated in a reaction mixture containing [c-32 P]ATP. As shown in Fig. 2A (lane 1 vs. lane 2) , free radioactive inorganicphosphate (Pi) was released from [c- 32 P]ATP in the presence of NBD , suggesting that this domain exhibits an intrinsic ATPase activity. To examine the possibility that the ATPase activity thus measured might be due to a contaminant enzyme activity, the catalytic Glu of this ABC transporter [29, 30] (corresponding to Glu479 in Rv1747, see Fig. 1A ) was mutated to a Gln residue. The mutant domain thus prepared did not exhibit any ATPase activity. In addition, this mutant showed a strong tendency to bind ATP [30] , resulting in a intense radioactivity spot observed in the loading zone, (Fig. 2A, lane 3) .
Rv1747 is a substrate for in vitro phosphorylation by PknF
To assess the ability of PknF 1-292 to phosphorylate NBD , an in vitro phosphorylation assay was performed by incubating purified PknF in the presence of [c- 32 P] ATP and purified NBD 1-559 . The reaction products were then separated by SDS-PAGE and the labeled proteins were identified by autoradiography. As shown in Fig. 3B (lane 2) , PknF could phosphorylate NBD , whereas NBD 1-559 alone was unable to incorporate [c- 32 P] (Fig. 3B, lane 3) , thus confirming that NBD 1-559 was a substrate for PknF. As previously observed for the myelin basic protein [14] , the autophosphorylation of PknF was markedly reduced in the presence of NBD 1-559 .
Both FHA domains are required for NBD 1-559 phosphorylation
The predicted presence of two FHA domains in the NBD of Rv1747 strongly suggested that Rv1747 could interact with a phosphoprotein, namely carrying phosphothreonine residues [31] . Since PknF is known to autophosphorylate on threonine residue(s) one the one hand, and is able to phosphorylate NBD 1-559 on the other hand, one could suspect that the FHA domains (both or either one of them) of Rv1747 would mediate a specific interaction required for its phosphorylation by the kinase. To check whether these phosphopeptide recognition motifs were involved in this phophorylation process, each FHA domain was mutagenized at a crucial position. The concerned punctual mutations consisted of Ala substitutions of the conserved Arg33, Ser47, and Asn69 residues of FHA1 and the Arg234, Ser248, and Asn270 residues of FHA2 corresponding, respectively, to Arg70, Ser85, and Asn107 in Rad53 (Fig. 1A) . In the Rad53 FHA1 domain [18, 31] , these three highly conserved residues have been shown to play a key role in the direct binding of the phosphopeptide, either by contacting the phosphopeptide backbone or via a phosphothreonine residue through a network of hydrogen bonding. Moreover, punctual mutations of these three conserved residues in EmbR (respectively, Arg312, Ser326, and Asn348) have been demonstrated to totally abolish phosphorylation of EmbR by PknH, as well as to prevent a specific interaction between these two proteins [15] . To test whether the FHA1 and/or the FHA2 domain of Rv1747 could mediate the interaction with PknF, in vitro phosphorylation assays were performed with either wild-type or mutated NBD . In each mutant of either FHA domain, the level of phosphorylation was strongly reduced as compared to the wild-type NBD 1-559 (decreased to 2-17% of the value measured for wild-type NBD 1-559 ; Fig. 4A, lanes 1-7; Fig. 4B , columns 1-7). Therefore, these data suggested that NBD 1-559 phosphorylation by PknF involved both FHA domains of Rv1747. To confirm this finding, a double mutant was prepared in which both Arg33 and Arg234 were mutated to Ala, in FHA1 and FHA2, respectively. As expected, such double mutation abolished almost completely the incorporation of radioactivity in NBD (2% of the wildtype value: Fig. 4A, lane 8; Fig. 4B, column 8 ).
Discussion
Although the regulatory networks involving STPKs and phosphatases represent an emerging theme in M. tuberculosis signaling cascades [10, 13, 15, 32] , little is known about the different protein partners, kinases and substrates, involved in this process. The main result of this study is the demonstration of a relationship between the PknF autokinase activity and its phosphorylating activity towards protein Rv1747. The latter reaction involves two FHA domains of Rv1747, one previously detected by in silico analysis [20] and another newly identified in this report.
On the basis of amino acid sequence analysis, it was predicted that Rv1747 would belong to the ABC transporter family of M. tuberculosis [21] . Protein Rv1747 contains not only the classical signature of an ABC transporter consisting of an NBD followed by a transmembrane domain, but also two N-terminal FHA domains. Given that (i) an ABC transporter requires the presence of at least two transmembrane domains and two NBDs to function and (ii) no additional putative half ABC transporter close to the rv1747 gene could be detected in the genome of M. tuberculosis, this suggests that Rv1747 would function in vivo as a homodimer rather than a heterodimer [21] . Based on sequence analysis and on the fact that no putative substratebinding protein can be predicted to be associated with Rv1747, this transporter can be considered as a putative exporter even though its substrate specificity remains to be determined [21] . Interestingly, Rv1747 displays an unusual topology with its NBD domain preceding its transmembrane domain in the primary structure, whereas a reverse topology is found in the vast majority of ABC transporters. This is the only example of an ABC transporter with such topology in M. tuberculosis [21] . In comparison, no transporter with a similar organization has been found in Bacillus subtilis [33] . In human, a transporter with a similar topology, BCRP (also called MXR or ABCG2), has been found to be involved in multidrug resistance in certain cancer cell lines [34] . Further work will be needed to determine the functional role of rv1747 in M. tuberculosis. The phosphorylation of the NBD of Rv1747 by PknF points to a possible mechanism of regulation of the transport mediated by Rv1747. Indeed, protein phosphorylation has been shown to regulate the activity of several ABC transporters including CFTR [35, 36] , multidrug resistance 1 (MDR1) [37] , and ABCA1, a cholesterol and phospholipid transporter [38] . Attempts to analyze the effect of phosphorylation on the ATPase activity of the NBD of Rv1747 have been so far unsuccessful, possibly because of the very low ATPase activity of the isolated NBD. In fact, phosphorylation can regulate the functioning of ABC transporters in a very subtle way. For instance, phosphorylation of MDR1 seems to modulate the drug transport by abolishing negative cooperativity between the drug-binding sites, while it does not affect the rate of ATPase activity [39] . Further investigation of the role of phosphorylation on the ATPase activity of the whole transporter Rv1747 might help to clarify this point.
Referring to eukaryotic systems, a large number of STPKs are known to catalyze autophosphorylation in an intramolecular process generally modulated by regulatory ligands, which allow rapid switching of numerous cellular functions. A similar situation can be envisaged for prokaryotes, here for PknF, which would behave like an ''eukaryotic-like'' STPK receptor, capable of modulating the activity of Rv1747 through phosphorylation. In eukaryotic organisms, the formation of such complex networks of interacting proteins involves conserved protein modules or domains that regulate signal transduction by mediating protein-protein interaction. Among these, the FHA domains mediate protein-protein interaction via a modular phosphopeptide recognition domain with a striking specificity for a phosphothreonine-containing epitope [18, 31] . Since a similar situation has been demonstrated to occur in M. tuberculosis through the FHAdependent phosphorylation of EmbR by PknH [15] , the presence of two FHA domains in Rv1747, as well as the adjacent chromosomal position of the pknF and Rv1747 genes, suggests that these modules mediate similar crossregulation between these two proteins.
The observation that phosphorylation of NBD 1-559 by PknF is abolished by several individual mutations present in both modules, shows that the two FHA domains of Rv1747 are required for the PknF/Rv1747 interaction. On this basis, it can be proposed that recruitment and phosphorylation of Rv1747 depend on interaction between its two non-redundant FHA domains and the autophosphorylated form of PknF. This suggests that PknF is autophosphorylated on at least two different threonine residues in order to interact simultaneously with the two FHA domains of Rv1747. Such mode of phosphorylation between an STPK and an ABC transporter provides a new framework for future investigation of possible phosphorylation of other ABC transporters in bacteria, such as Streptomyces coelicolor. Indeed, in this bacterial species, the sco1806 gene encodes a putative ABC transporter which seems to possess, as well as Rv1747, two FHA domains. Moreover, since some ABC transporters are able to export a wide diversity of substrates across biological membranes including sugars and drugs, the results obtained with M. tuberculosis open new perspectives to decipher the molecular mechanisms involved in mycobacterial physiology and pathogenicity. Currently, experiments are in progress to overproduce the entire Rv1747 protein and to identify the precise role of phosphorylation in transport activity.
